<DOC>
	<DOCNO>NCT00215254</DOCNO>
	<brief_summary>The purpose study examine effectiveness tolerability quetiapine treatment social anxiety disorder ( SAD ) . The hypothesis quetiapine effective well-tolerated patient social anxiety disorder .</brief_summary>
	<brief_title>Quetiapine Social Anxiety Disorder</brief_title>
	<detailed_description>This eight week , randomize , double-blind , placebo-controlled trial quetiapine ( 100-400 mg/day ) social anxiety disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>adult outpatient 1865 year age primary diagnosis social anxiety disorder , use DSMIV criterion minimum CGI severity score 4 baseline minimum BSPS score 20 baseline write informed consent negative serum pregnancy test woman childbearing potential current DSMIV diagnosis bipolar disorder , schizophrenia psychotic disorder , cognitive disorder due general medical condition current primary anxiety disorder SAD current primary depression history substance abuse dependence last 6 month suicide risk serious suicide attempt within last year clinically significant medical condition laboratory abnormality woman childbearing potential unwilling practice acceptable method contraception concomitant medication use psychotropic purpose history hypersensitivity quetiapine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>quetiapine</keyword>
	<keyword>social anxiety disorder</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>pilot study</keyword>
</DOC>